Investment
Features
FeesSafety
Academy
More
Pluang+

Bread Financial's preferred shares yield 8.6%, backed by strong deposit growth and solid loan performance.

Market News
11 Aug 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Bread Financial offers attractive income through its Series A preferred shares yielding 8.6%. The bank maintains a strong net interest margin of 18.5%, supported by high asset yields and robust deposit and loan growth. Deposit growth exceeds loan growth, improving the loan-to-deposit ratio to 111% and reducing reliance on external funding. With the common stock rallying sharply, preferred shares are favored for stable income amid flat net interest income.

More News

Bitcoin dips below $64,000 ahead of US inflation data, traders cautious on next move.

Bitcoin dips below $64,000 ahead of US inflation data, traders cautious on next move.

Bitcoin fell below $64,000 on August 11, 2026, testing a key support level around $63,800 as traders await the US Consumer Price Index (CPI) report. The market shows cautious positioning with Bitcoin trading in a tight range between roughly $63,766 a...

Market News
Neutral
4 hours ago
C3 Metals completes 3DIP survey at Bellas Gate, identifies deep copper-gold targets for drilling.

C3 Metals completes 3DIP survey at Bellas Gate, identifies deep copper-gold targets for drilling.

C3 Metals has finished a large 3D electrical geophysical survey at its Bellas Gate copper-gold project in Jamaica, revealing multiple deep chargeability anomalies. These anomalies align with known porphyry belts and new prospects, guiding an upcoming...

Market News
Bullish
4 hours ago
374Water's Q2 revenue jumps on milestone with Orange County Sanitation District contract

374Water's Q2 revenue jumps on milestone with Orange County Sanitation District contract

374Water reported a sharp rise in preliminary Q2 revenue to over $2.2 million, up from $0.6 million a year ago, mainly due to completing a Factory Acceptance Test for the Orange County Sanitation District project. This milestone enables the company t...

Company Fundamentals
Bullish
4 hours ago
BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.

BioCryst Pharmaceuticals reported its first full year of profitability in 2025 and posted $218.25 million in revenue for Q2 2026, a 33.6% increase year-over-year. The company, known for its rare disease drug Orladeyo, which generated $158.2 million i...

Market News
Bullish
4 hours ago
Teledyne Technologies to buy Varex Imaging for $1.1B, boosting healthcare and X-ray tech.

Teledyne Technologies to buy Varex Imaging for $1.1B, boosting healthcare and X-ray tech.

Teledyne Technologies will acquire Varex Imaging in an all-cash deal valued at $1.1 billion, paying $18.90 per share. This acquisition expands Teledyne's healthcare equipment portfolio and strengthens its X-ray technology capabilities. The purchase p...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App